Jane Street Group, LLC Revance Therapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$2.57 - $2.57 $69,133 - $69,133	26,900 New	26,900 $69,000
Q1 2022 May 17, 2022	BUY	$12.36 - $20.31 $741,600 - $1.22 Million	60,000 Added 147.06%	100,800 $1.97 Million
Q4 2021 Feb 15, 2022	BUY	$12.46 - $27.87 $388,752 - $869,544	31,200 Added 325.0%	40,800 $666,000
Q2 2021 Aug 16, 2021	SELL	$26.8 - $31.84 $495,800 - $589,040	-18,500 Reduced 65.84%	9,600 $285,000
Q4 2020 Feb 17, 2021	BUY	$23.41 - $28.34 $657,821 - $796,354	28,100 New	28,100 $796,000

10.6M

360K

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.